Nick Otranto currently serves as the Director of US Vaccines, focusing on Organized Customer Access and Reimbursement at Merck since March 2024. Prior to this, Nick held the position of Director of Oncology Market Access Strategy at GSK, where responsibilities included leading the US market access strategy for Zejula, overseeing pricing, contracting, and patient support services, and receiving notable awards for performance. Nick's career at Merck also included roles in US Payer Marketing for Keytruda, Bridion, and various therapeutic areas. Earlier positions at ApotheCom and Aventria Health Group involved leading strategy and client services for clients such as Novo Nordisk. Nick holds a Bachelor of Arts in Business Administration from Muhlenberg College, an MBA in Pharmaceutical and Healthcare Marketing from Saint Joseph's University, and has completed executive education programs at Duke University and Thayer Leadership.
This person is not in any teams
This person is not in any offices